The UCL BRC Cancer Theme recently awarded grants to pump-prime experimental medicine research aligned to one of our three strategic (see below) objectives or in the area of early detection of cancer.
The theme received a total of 21 applications, of which 7 were shortlisted. After a rigorous scoring process by the BRC Cancer Programme Board 5 applications (listed below) were granted funding to the tune of £310K.
The proposals submitted had to meet three key objectives:
- Improving the therapeutic index in non-chemotherapy cancer treatment
- Tumour heterogeneity and targeted therapy
- Cancer Immunotherapy
And
- Early detection of cancer
BRC Cancer Theme Call Proposals Awarded:
1. Single-Cell Analysis of Microbiome-Epithelial Communication in CRC
2. Investigating the role of RNA-editing in cancer evolution and anti-tumour immunity
3. T-iPSC approaches to T-cell immunotherapy for cancer
4. Identification of allosteric inhibitors of the XPF complex to overcome platinum treatment resistance in Neuroendocrine Prostate Cancer (NEPC)
5. A method to accurately deconvolute the tumour immune microenvironment
